Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ebfd716a6d868cec0fdcf2af2480107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7aa001f3235c07b0298867908d45e21 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-6018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15034 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
2005-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1b865fa5368876cb6ce1fae36c31369 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4a91c39377781f3ae7e4aca6945857b |
publicationDate |
2007-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20070085254-A |
titleOfInvention |
Improved Adenovirus Vectors and Their Uses |
abstract |
The present invention is directed to recombinant adenovirus vectors based on adenoviruses that fight against pre-existing immunity in a small number of human populations and have chimeric capsids. Chimeric capsids contain hepson proteins from adenovirus serotypes that counter at least pre-existing immunity at low rates of human populations and fiber proteins with knob domains of human adenoviruses that bind coxsackieviruses and adenovirus receptors (CARs). Include. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10077430-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014081229-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101429696-B1 |
priorityDate |
2004-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |